| pubmed-article:12767844 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12767844 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
| pubmed-article:12767844 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
| pubmed-article:12767844 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12767844 | lifeskim:mentions | umls-concept:C0314787 | lld:lifeskim |
| pubmed-article:12767844 | lifeskim:mentions | umls-concept:C0005775 | lld:lifeskim |
| pubmed-article:12767844 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:12767844 | lifeskim:mentions | umls-concept:C0332325 | lld:lifeskim |
| pubmed-article:12767844 | lifeskim:mentions | umls-concept:C0075629 | lld:lifeskim |
| pubmed-article:12767844 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:12767844 | pubmed:dateCreated | 2003-5-27 | lld:pubmed |
| pubmed-article:12767844 | pubmed:abstractText | The emergence of multidrug-resistant (MDR) Acinetobacter baumannii poses a therapeutic problem. The aim of this study was to assess the risk factors for nosocomial MDR-A. baumannii bloodstream infection (BSI) and the efficacy of ampicillin-sulbactam (A/S) in its treatment. Of 94 nosocomial A. baumannii BSI during the year 2000, 54% involved MDR strains, 81% of which were genetically related. Various risk factors for MDR-A. baumannii were found, of which intensive-care unit admission and prior aminoglycoside therapy were independently associated with MDR-A. baumannii acquisition on multivariate analysis. Of MDR-A. baumannii BSI cases, 65% received A/S and 35% inadequate antibiotic therapy, whereas of 43 non-MDR cases, 86% were treated according to susceptibility and 14% inappropriately with antibiotics to which these organisms were resistant. Crude mortality was comparable in the adequately treated groups. Respective mortalities among patients treated adequately and inadequately were 41.4 and 91.7% (p<0.001). Among severely ill patients, A/S therapy significantly decreased the risk of death (P=0.02 OR=7.64). MDR-A. baumannii has become highly endemic in our institution. A/S appears to be one of the last effective and safe empirical resorts for treatment of MDR A. baumannii BSI. | lld:pubmed |
| pubmed-article:12767844 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12767844 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12767844 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12767844 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12767844 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12767844 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12767844 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12767844 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12767844 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12767844 | pubmed:month | May | lld:pubmed |
| pubmed-article:12767844 | pubmed:issn | 0195-6701 | lld:pubmed |
| pubmed-article:12767844 | pubmed:author | pubmed-author:PorathAA | lld:pubmed |
| pubmed-article:12767844 | pubmed:author | pubmed-author:AlkanMM | lld:pubmed |
| pubmed-article:12767844 | pubmed:author | pubmed-author:GiladJJ | lld:pubmed |
| pubmed-article:12767844 | pubmed:author | pubmed-author:AlmogYY | lld:pubmed |
| pubmed-article:12767844 | pubmed:author | pubmed-author:SchlaefferFF | lld:pubmed |
| pubmed-article:12767844 | pubmed:author | pubmed-author:RiesenbergKK | lld:pubmed |
| pubmed-article:12767844 | pubmed:author | pubmed-author:BorerAA | lld:pubmed |
| pubmed-article:12767844 | pubmed:author | pubmed-author:RimalBB | lld:pubmed |
| pubmed-article:12767844 | pubmed:author | pubmed-author:SmolyakovRR | lld:pubmed |
| pubmed-article:12767844 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12767844 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:12767844 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12767844 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12767844 | pubmed:pagination | 32-8 | lld:pubmed |
| pubmed-article:12767844 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:meshHeading | pubmed-meshheading:12767844... | lld:pubmed |
| pubmed-article:12767844 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12767844 | pubmed:articleTitle | Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. | lld:pubmed |
| pubmed-article:12767844 | pubmed:affiliation | Infectious Disease Institute, Soroka University Medical Centre and the Faculty for Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. | lld:pubmed |
| pubmed-article:12767844 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12767844 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12767844 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12767844 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12767844 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12767844 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12767844 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12767844 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12767844 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12767844 | lld:pubmed |
